Top

Respiratory Research

Published in:

Open Access 01-12-2007 | Research

Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27^kip1

Authors: Maiko Kadowaki, Shiro Mizuno, Yoshiki Demura, Shingo Ameshima, Isamu Miyamori, Takeshi Ishizaki

Published in: Respiratory Research | Issue 1/2007

Abstract

Background

Hypoxia induces the proliferation of pulmonary arterial smooth muscle cell (PASMC) in vivo and in vitro, and prostacyclin analogues are thought to inhibit the growth of PASMC. Previous studies suggest that p27^kip1, a kind of cyclin-dependent kinase inhibitor, play an important role in the smooth muscle cell proliferation. However, the mechanism of hypoxia and the subcellular interactions between p27^kip1 and prostacyclin analogues in human pulmonary arterial smooth muscle cell (HPASMC) are not fully understood.

Methods

We investigated the role of p27^kip1 in the ability of Beraprost sodium (BPS; a stable prostacyclin analogue) to inhibit the proliferation of HPASMC during hypoxia. To clarify the biological effects of hypoxic air exposure and BPS on HPASMC, the cells were cultured in a hypoxic chamber under various oxygen concentrations (0.1–21%). Thereafter, DNA synthesis was measured as bromodeoxyuridine (BrdU) incorporation, the cell cycle was analyzed by flow cytometry with propidium iodide staining. The p27^kip1 mRNA and protein expression and it's stability was measured by real-time RT-PCR and Western blotting. Further, we assessed the role of p27^kip1 in HPASMC proliferation using p27^kip1 gene knockdown using small interfering RNA (siRNA) transfection.

Results

Although severe hypoxia (0.1% oxygen) suppressed the proliferation of serum-stimulated HPASMC, moderate hypoxia (2% oxygen) enhanced proliferation in accordance with enhanced p27^kip1 protein degradation, whereas BPS suppressed HPASMC proliferation under both hypoxic and normoxic conditions by suppressing p27^kip1 degradation with intracellular cAMP-elevation. The 8-bromo-cyclic adenosine monophosphate (8-Br-cAMP), a cAMP analogue, had similar action as BPS in the regulation of p27^kip1. Moderate hypoxia did not affect the stability of p27^kip1 protein expression, but PDGF, known as major hypoxia-induced growth factors, significantly decreased p27^kip1 protein stability. We also demonstrated that BPS and 8-Br-cAMP suppressed HPASMC proliferation under both hypoxic and normoxic conditions by blocking p27^kip1 mRNA degradation. Furthermore, p27^kip1 gene silencing partially attenuated the effects of BPS and partially restored hypoxia-induced proliferation.

Conclusion

Our study suggests that moderate hypoxia induces HPASMC proliferation, which is partially dependent of p27^kip1 down-regulation probably via the induction of growth factors such as PDGF, and BPS inhibits both the cell proliferation and p27^kip1 mRNA degradation through cAMP pathway.

Jeffery TK, Wanstall JC: Pulmonary vascular remodelling in hypoxic rats: effects of amlodipine, alone and with perindopril. Eur J Pharmacol 2001,416(1–2):123–31.CrossRefPubMed

Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid L: Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol 1979,236(6):H818–27.PubMed

Rabinovitch M, Konstam MA, Gamble WJ, Papanicolaou N, Aronovitz MJ, Treves S, Reid L: Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats. Circ Res 1983,52(4):432–41.CrossRefPubMed

Biernacki W, Flenley DC, Muir AL, MacNee W: Pulmonary hypertension and right ventricular function in patients with COPD. Chest 1988,94(6):1169–75.CrossRefPubMed

Part One MacNee W: Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994,150(3):833–52.CrossRefPubMed

Semmens M, Reid L: Pulmonary arterial muscularity and right ventricular hypertrophy in chronic bronchitis and emphysema. Br J Dis Ches 1974, 68:253–63.CrossRef

Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999,103(5):691–6.CrossRefPubMedPubMedCentral

Yu L, Quinn DA, Garg HG, Hales CA: Cyclin-dependent kinase inhibitor p27 ^kip1 , but not p21 ^WAF1/Cip1 , is required for inhibition of hypoxia-induced pulmonary hypertension and remodeling by heparin in mice. Circ Res 2005,97(9):937–45.CrossRefPubMed

Cooper AL, Beasley D: Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells. Am J Physiol 1999,277(4 Pt 2):H1326–37.PubMed

10.

Frid MG, Aldashev AA, Dempsey EC, Stenmark KR: Smooth muscle cells isolated from discrete compartments of the mature vascular media exhibit unique phenotypes and distinct growth capabilities. Circ Res 1997,81(6):940–52.CrossRefPubMed

11.

Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM: Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells. Life Sci 2005,77(1):28–38.CrossRefPubMed

12.

Schultz K, Fanburg BL, Beasley D: Hypoxia and hypoxia-inducible facter-1α promote growth facter-induced proliferation of human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2006, 290:H2528-H2534.CrossRefPubMed

13.

Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, Barst RJ: Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004,43(12 Suppl S):56S-61S.CrossRefPubMed

14.

Clapp LH, Finney P, Turcato S, Tran S, Rubin LJ, Tinker A: Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery. Am J Respir Cell Mol Biol 2002,26(2):194–201.CrossRefPubMed

15.

Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, Alger LA, Tuder RM, Voelkel NF: Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest 1999,103(11):1509–15.CrossRefPubMedPubMedCentral

16.

Nishio S, Kurumatani H: Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue. Nippon Yakurigaku Zasshi 2001,117(2):123–30.CrossRefPubMed

17.

Galie N, Humbert M, Vachiery JL, Vizza CD, Kneussl M, Manes A, Sitbon O, Torbicki A, Delcroix M, Naeije R, Hoeper M, Chaouat A, Morand S, Besse B, Simonneau G, Arterial Pulmonary Hypertension and Beraprost European (ALPHABET) Study Group: Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002,39(9):1496–502.CrossRefPubMed

18.

Lievre M, Morand S, Besse B, Fiessinger JN, Boissel JP: Oral Beraprost sodium, a prostaglandin I2 analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Circulation 2000,102(4):426–31.CrossRefPubMed

19.

Kainoh M, Maruyama I, Nishio S, Nakadate T: Enhancement by beraprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP level. Biochem Pharmacol 1991,41(8):1135–40.CrossRefPubMed

20.

Hatakeyama M, Weinberg RA: The role of RB in cell cycle control. Prog Cell Cycle Res 1995, 1:9–19.CrossRefPubMed

21.

Fasciano S, Patel RC, Handy I, Patel CV: Regulation of vascular smooth muscle proliferation by heparin: inhibition of cyclin-dependent kinase 2 activity by p27 ^kip1 . J Biol Chem 2005,280(16):15682–9.CrossRefPubMedPubMedCentral

22.

Fouty BW, Grimison B, Fagan KA, Le Cras TD, Harral JW, Hoedt-Miller M, Sclafani RA, Rodman DM: p27 ^kip1 is important in modulating pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2001,25(5):652–8.CrossRefPubMed

23.

Yu L, Quinn DA, Garg HG, Hales CA: Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension. Biochem Biophys Res Commun 2006,345(4):1565–72.CrossRefPubMed

24.

Ii M, Hoshiga M, Fukui R, Negoro N, Nakakoji T, Nishiguchi F, Kohbayashi E, Ishihara T, Hanafusa T: Beraprost sodium regulates cell cycle in vascular smooth muscle cells through cAMP signaling by preventing down-regulation of p27 ^kip1 . Cardiovasc Res 2001,52(3):500–8.CrossRefPubMed

25.

Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV: Hypoxia inhibits G ₁ /S transition through regulation of p27 expression. J Biol Chem 2001,276(11):7919–26.CrossRefPubMed

26.

Graff P, Amellem O, Seim J, Stokke T, Pettersen EO: The role of p27 in controlling the oxygen-dependent checkpoint of mammalian cells in late G1. Anticancer Res 2005,25(3B):2259–67.PubMed

27.

Wang G, Reisdorph R, Clark RE Jr, Miskimins R, Lindahl R, Miskimins WK: Cyclin dependent kinase inhibitor p27 ^kip1 is upregulated by hypoxia via an ARNT dependent pathway. J Cell Biochem 2003,90(3):548–60.CrossRefPubMed

28.

Mizuno S, Kadowaki M, Demura Y, Ameshima S, Miyamori I, Ishizaki T: p42/44 Mitogen-activated protein kinase regulated by p53 and nitric oxide in human pulmonary arterial smooth muscle cells. Am J Respir Cell Mol Biol 2004,31(2):184–92.CrossRefPubMed

29.

Fukuchi K, Tomoyasu S, Watanabe H, Tsuruoka N, Gomi K: G ₁ accumulation caused by iron deprivation with deferoxamine does not accompany change of pRB status in ML-1 cells. Biochim Biophys Acta 1997,1357(3):297–305.CrossRefPubMed

30.

Cogo A, Napolitano G, Michoud MC, Barbon DR, Ward M, Martin JG: Effects of hypoxia on rat airway smooth muscle cell proliferation. J Appl Physiol 2003,94(4):1403–9.CrossRefPubMed

31.

Krick S, Hanze J, Eul B, Savai R, Seay U, Grimminger F, Lohmeyer J, Klepetko W, Seeger W, Rose F: Hypoxia-driven proliferation of human pulmonary artery fibroblasts: cross-talk between HIF-1alpha and an autocrine angiotensin system. FASEB J 2005,19(7):857–9.PubMed

32.

Norman JT, Clark IM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000,58(6):2351–66.CrossRefPubMed

33.

Sahai A, Mei C, Pattison TA, Tannen RL: Chronic hypoxia induces proliferation of cultured mesangial cells: role of calcium and protein kinase C. Am J Physiol 1997,273(6 Pt 2):F954–60.PubMed

34.

Eto I: Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27 ^kip1 , a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells. Cancer Cell Int 2006, 6:20.CrossRefPubMedPubMedCentral

35.

Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997,3(2):231–4.CrossRefPubMed

36.

Philipp-Staheli J, Kim KH, Liggitt D, Gurley KE, Longton G, Kemp CJ: Distinct roles for p53, p27 ^kip1 , and p21 ^Cip1 during tumor development. Oncogene 2004,23(4):905–13.CrossRefPubMed

37.

Servant MJ, Coulombe P, Turgeon B, Meloche S: Differential regulation of p27 ^kip1 expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol 2000,148(3):543–56.CrossRefPubMedPubMedCentral

38.

Marra DE, Simoncini T, Liao JK: Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21 ^Waf1 and p27 ^kip1 . Circulation 2000,102(17):2124–30.CrossRefPubMed

39.

Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, Uehara Y: Induction of p27 ^kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 1997,15(6):629–37.CrossRefPubMed

40.

Dong Y, Aronsson M, Gustafsson JA, Okret S: The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem 1989,264(23):13679–83.PubMed

41.

Jungmann RA, Kelley DC, Miles MF, Milkowski DM: Cyclic AMP regulation of lactate dehydrogenase. Isoproterenol and N6,O2-dibutyryl cyclic amp increase the rate of transcription and change the stability of lactate dehydrogenase a subunit messenger RNA in rat C6 glioma cells. J Biol Chem 1983,258(8):5312–8.PubMed

42.

Sakaue M, Hoffman BB: cAMP regulates transcription of the alpha 2A adrenergic receptor gene in HT-29 cells. J Biol Chem 1991,266(9):5743–9.PubMed

43.

Sakakibara K, Kubota K, Worku B, Ryer EJ, Miller JP, Koff A, Kent KC, Liu B: PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem 2005,280(27):25470–7.CrossRefPubMed

44.

Vidal A, Millard SS, Miller JP, Koff A: Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem 2002,277(19):16433–40.CrossRefPubMed

45.

Dong JM, Leung T, Manser E, Lim L: cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem 1998,273(35):22554–62.CrossRefPubMed

46.

Laufs U, Marra D, Node K, Liao JK: 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27 ^kip1 . J Biol Chem 1999,274(31):21926–31.CrossRefPubMed

47.

Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, McMurtry IF: Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004,287(4):L656–64.CrossRefPubMed

48.

Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P: Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 2005,97(2):185–91.CrossRefPubMed

Title: Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27kip1
Authors: Maiko Kadowaki
Shiro Mizuno
Yoshiki Demura
Shingo Ameshima
Isamu Miyamori
Takeshi Ishizaki
Publication date: 01-12-2007
Publisher: BioMed Central
Published in: Respiratory Research / Issue 1/2007
Electronic ISSN: 1465-993X
DOI: https://doi.org/10.1186/1465-9921-8-77

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effect of hypoxia and Beraprost sodium on human pulmonary arterial smooth muscle cell proliferation: the role of p27^kip1

Abstract

Background

Methods

Results

Conclusion

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2007

In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices

A novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy

Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life

LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms

In-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue

Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page